Nephros Inc.

NEPH Healthcare Medical Instruments & Supplies

Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024. In the quarter to June 2026, revenue grew 36.2%, EPS grew 450.0% and free cash flow fell 31.5%, each against the same quarter a year earlier.

3.65 0.14 +3.99%
Market cap
$38.1M
P/E
23.4×
Fwd P/E
76.0×
Dividend yield
—
F-score
7/9
Altman Z
−3.26
Beneish M
−2.60
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

36.38 46.12 45.29 22.91
P/S ratio
2.80 2.76 1.66 1.87
P/FCF ratio
19.35 34.07 0.00 0.00
P/Operating CF
507.02 225.16 (18.99) 56.92
P/B ratio
5.02 5.08 2.97 3.24
EV/Sales
2.51 2.47 1.45 1.64
EV/EBITDA
28.37 36.10 34.53 19.32
EV/FCF
17.36 30.52 (58.62) (43.34)
Current Ratio
4.34 4.06 4.55 4.07
Net Debt/EBITDA
(14.86) (108.00) (32.40) (3.78)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.75% 2.17% 2.21% 4.36%
Free Cash Flow Yield
5.17% 2.94% (1.49%) (2.03%)
Free Cash Flow per Share
0.01 0.02 (0.16) 0.06
Book value per Share
0.94 0.96 1.00 1.10
Free Cash Flow
0.10 0.23 (1.67) 0.68
EV/EBIT
31.16 40.48 40.96 20.75
Other line items

Show all line items

Columns are period end dates